hotspot -WSS

hotspot

author：fashion 2025-10-01 11:38:27 Page View：46

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Congress likely to miss an opportunity to fix drug shortages issue
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

leisure time

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

Argenx drug significantly slows progression of nerve disorder

AdobeBelgiandrugmakerArgenxsaidMondaythatitsantibodytreatmentcalledVyvgartsignificantlydelayedthepro

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Iran'sPresidentEbrahimRaisi,center,andKenya'sPresidentWilliamRuto,right,arrivetogiveajointpressconfe

hotspot

explore

leisure time

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'